scispace - formally typeset
X

Xing-Wei Wong

Researcher at University of Canterbury

Publications -  16
Citations -  1096

Xing-Wei Wong is an academic researcher from University of Canterbury. The author has contributed to research in topics: Insulin & Insulin resistance. The author has an hindex of 13, co-authored 16 publications receiving 1083 citations.

Papers
More filters
Journal ArticleDOI

Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change.

TL;DR: Reductions in mortality were observed compared with a retrospective hyperglycaemic cohort and the SPRINT protocol achieved a high level of glycaemic control on a severely ill critical cohort population.
Journal ArticleDOI

A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison.

TL;DR: Tight control was achieved in simulation using a protocol that is easy to implement in an intensive care unit and effective in achieving and maintaining normoglycemia in critical illness.
Journal ArticleDOI

Model-based glycaemic control in critical care—A review of the state of the possible

TL;DR: There are many opportunities and unanswered questions remaining on which model-based control research can have significant clinical impact, and there is an emerging, strong need for the more rigorous analysis and methods that model- based control methods bring to this type of problem.
Journal ArticleDOI

A pilot study of the SPRINT protocol for tight glycemic control in critically Ill patients.

TL;DR: Control of blood glucose level was achieved using a protocol implemented by the nursing staff without the need for physician intervention or interpretation, where control is defined as maximizing time within a desired band.
Journal ArticleDOI

A Novel, Model-Based Insulin and Nutrition Delivery Controller for Glycemic Regulation in Critically Ill Patients

TL;DR: Overall, tight glycemic regulation is achieved in a broad critical care cohort with optimized insulin and nutrition delivery, effectively managing glycemia even with high effective insulin resistance.